NO20001612D0 - Oralt preparat - Google Patents

Oralt preparat

Info

Publication number
NO20001612D0
NO20001612D0 NO20001612A NO20001612A NO20001612D0 NO 20001612 D0 NO20001612 D0 NO 20001612D0 NO 20001612 A NO20001612 A NO 20001612A NO 20001612 A NO20001612 A NO 20001612A NO 20001612 D0 NO20001612 D0 NO 20001612D0
Authority
NO
Norway
Prior art keywords
oral preparation
oral
preparation
Prior art date
Application number
NO20001612A
Other languages
English (en)
Other versions
NO20001612L (no
Inventor
Noritaka Ii
Toshio Murakami
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20001612D0 publication Critical patent/NO20001612D0/no
Publication of NO20001612L publication Critical patent/NO20001612L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
NO20001612A 1997-09-30 2000-03-28 Oralt preparat NO20001612L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26544197 1997-09-30
PCT/JP1998/004374 WO1999016470A1 (fr) 1997-09-30 1998-09-29 Preparation orale

Publications (2)

Publication Number Publication Date
NO20001612D0 true NO20001612D0 (no) 2000-03-28
NO20001612L NO20001612L (no) 2000-05-30

Family

ID=17417203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001612A NO20001612L (no) 1997-09-30 2000-03-28 Oralt preparat

Country Status (11)

Country Link
US (1) US20030069213A1 (no)
EP (1) EP1020193A4 (no)
JP (2) JP4346817B2 (no)
KR (1) KR20010030798A (no)
CN (1) CN1152717C (no)
AU (1) AU9187598A (no)
CA (1) CA2305179A1 (no)
NO (1) NO20001612L (no)
RU (1) RU2184570C2 (no)
TW (1) TW537897B (no)
WO (1) WO1999016470A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0007760D0 (en) * 2000-03-30 2000-05-17 Smithkline Beckman Corp Composition
JP4706096B2 (ja) * 2000-10-23 2011-06-22 大正製薬株式会社 不快な味を呈する塩基性薬物配合製剤
JP3405342B2 (ja) * 2001-09-11 2003-05-12 味の素株式会社 矯味、矯臭物質の付着した粒状物の製造方法
JP4925534B2 (ja) * 2001-09-27 2012-04-25 宗鉄 丁 漢方薬配合チュアブル錠
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
WO2003075918A1 (fr) * 2002-03-14 2003-09-18 Daiichi Suntory Pharma Co.,Ltd. Comprime contenant du chlorhydrate de pilsicainide (voie humide)
KR100465537B1 (ko) * 2002-06-05 2005-01-13 경동제약 주식회사 레보설피라이드 액제 조성물
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
US20040180110A1 (en) 2003-03-14 2004-09-16 Atul Mistry Chewing gum and confectionery compositions containing an endothermic agent
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
KR100553019B1 (ko) * 2003-06-19 2006-02-16 현대약품공업주식회사 씹어 먹는 파모티딘 정제의 제조방법
KR20120064735A (ko) * 2004-04-01 2012-06-19 아지노모토 가부시키가이샤 나테글리니드 함유 제제
US20080207624A1 (en) * 2004-05-11 2008-08-28 Osamu Sugita Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
JP4895819B2 (ja) * 2004-10-29 2012-03-14 大鵬薬品工業株式会社 プロピベリン含有経口粉粒状製剤及びその製造法
JP4860940B2 (ja) * 2005-04-21 2012-01-25 株式会社 資生堂 イオントフォレーシスによるトラネキサム酸の経皮送達
EP1954298A4 (en) * 2005-11-28 2012-10-31 Imaginot Pty Ltd DISPENSING SYSTEM FOR ORAL THERAPEUTIC CONNECTION
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
JP2007217308A (ja) * 2006-02-14 2007-08-30 Kobayashi Pharmaceut Co Ltd 口中清涼化組成物
JP5345273B2 (ja) * 2006-02-14 2013-11-20 小林製薬株式会社 口中清涼化組成物
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
FR2915658B1 (fr) * 2007-05-02 2013-10-11 Jean Francois Joseph Michel Letavernier Emploi du mannitol pour la modulation des perceptions gustatives et olfactives des aliments,boissons et complements alimentaires
EP2065038A1 (en) 2007-11-30 2009-06-03 Pharnext New therapeutic approaches for treating Charcot-Marie-Tooth disease
KR100846095B1 (ko) * 2008-04-02 2008-07-14 현대약품 주식회사 염산 페닐레프린을 포함하는 약학 조성물
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
JP5309977B2 (ja) * 2008-12-26 2013-10-09 ライオン株式会社 チュアブル錠
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
US9393241B2 (en) 2009-06-02 2016-07-19 Pharnext Compositions for treating CMT and related disorders
EP2263665A1 (en) 2009-06-02 2010-12-22 Pharnext New compositions for treating CMT and related disorders
JP5397026B2 (ja) * 2009-06-05 2014-01-22 ゼリア新薬工業株式会社 内用液剤
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
GB201006218D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
EP2632563B1 (en) 2010-10-27 2018-07-25 Future Engineering AS A device for a cleaning unit for hydraulic oil and lubricating oil
JP6300906B2 (ja) 2013-06-05 2018-03-28 ファーネクストＰｈａｒｎｅｘｔ 併用医薬有効成分（ａｐｉ）用安定性経口液剤
JP2015040206A (ja) * 2013-08-23 2015-03-02 高田製薬株式会社 刺激性（収斂性、酸味、苦み）のある薬物を含有する口腔内速崩壊錠およびその製造方法
CN106456484A (zh) * 2014-06-30 2017-02-22 乐敦制药株式会社 外用剂
JP6532153B2 (ja) * 2015-01-30 2019-06-19 ライオン株式会社 内服用錠剤
JP6101831B1 (ja) * 2016-02-15 2017-03-22 物産フードサイエンス株式会社 塩味増強剤
US10383870B2 (en) 2016-06-10 2019-08-20 Pharnext Early treatment of CMT disease
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
US11666532B2 (en) 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
JP7296198B2 (ja) * 2018-06-15 2023-06-22 小林製薬株式会社 医薬組成物
CN117618581B (zh) * 2023-12-07 2024-04-09 广州金叶健康科技有限公司 一种中药口服液用矫味剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2174004B (en) * 1985-04-23 1988-11-30 American Cyanamid Co Pharmaceutical tablet preparations
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.
JP2726498B2 (ja) * 1988-06-27 1998-03-11 第一製薬株式会社 経口固形製剤
HUT65753A (en) * 1991-04-04 1994-07-28 Procter & Gamble Chewable antacid compositions and process for production of them
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
AU2912695A (en) * 1994-08-12 1996-03-07 Henry C Caldwell Oral compositions of h2-antagonists
JP2705787B2 (ja) * 1994-09-30 1998-01-28 山之内製薬株式会社 苦味改善易服用性ｈ▲２▼ブロッカー固形製剤
JPH10273435A (ja) * 1997-01-29 1998-10-13 Fujisawa Pharmaceut Co Ltd 内服用液剤
JP3783993B2 (ja) * 1997-07-24 2006-06-07 エーザイ株式会社 製剤組成物及びその製造方法

Also Published As

Publication number Publication date
TW537897B (en) 2003-06-21
CN1152717C (zh) 2004-06-09
JP4346817B2 (ja) 2009-10-21
NO20001612L (no) 2000-05-30
JP5097748B2 (ja) 2012-12-12
RU2184570C2 (ru) 2002-07-10
WO1999016470A1 (fr) 1999-04-08
KR20010030798A (ko) 2001-04-16
EP1020193A1 (en) 2000-07-19
US20030069213A1 (en) 2003-04-10
AU9187598A (en) 1999-04-23
EP1020193A4 (en) 2006-05-24
CN1280506A (zh) 2001-01-17
JP2009185082A (ja) 2009-08-20
CA2305179A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
NO20001612D0 (no) Oralt preparat
NO308394B1 (no) Oralt preparat
ID20233A (id) Komposisi oral
DE69811634T2 (de) Zahnbürste
ATE537728T1 (de) Zahnbürste
ATE231349T1 (de) Zahnbürste
DE69815089D1 (de) Selbstaufrichtende zahnbürste
NO983624D0 (no) Biocid preparat i fast form
NO20005399D0 (no) Farmasøytisk preparat
DE59806063D1 (de) Zahnbürste
DE69713171D1 (de) Mundpflegezubereitung
DE69809270T2 (de) Zahnbürste
ID20466A (id) Komposisi oral
DE29709865U1 (de) Zahnbürste
FI951155A (fi) Farmaseuttinen valmiste
DE29702508U1 (de) Zahnbürste
NO20011313D0 (no) Nytt preparat
DE29706076U1 (de) Zahnmedizinischer Aufbaupfosten
NO20011312D0 (no) Nytt preparat
ID23663A (id) Persiapan kaprolaktam
DE29723604U1 (de) Dentalkonstruktion
KR980000415U (ko) 치솔
NO986033D0 (no) Medisinsk preparat
DE29805469U1 (de) Peloidzubereitung
DE29819078U1 (de) Glucuron Präparat